These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 34389210)
21. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study. Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042 [TBL] [Abstract][Full Text] [Related]
22. Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation. Riesenhuber M; Spannbauer A; Gwechenberger M; Pezawas T; Schukro C; Stix G; Schneider M; Goliasch G; Anvari A; Wrba T; Khazen C; Andreas M; Laufer G; Hengstenberg C; Gyongyosi M Clin Res Cardiol; 2021 Jun; 110(6):884-894. PubMed ID: 33566185 [TBL] [Abstract][Full Text] [Related]
23. Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation. Seo J; Kim DY; Cho I; Hong GR; Ha JW; Shim CY PLoS One; 2020; 15(6):e0235230. PubMed ID: 32589674 [TBL] [Abstract][Full Text] [Related]
24. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation. Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846 [TBL] [Abstract][Full Text] [Related]
25. Tricuspid valve disease and cardiac implantable electronic devices. Andreas M; Burri H; Praz F; Soliman O; Badano L; Barreiro M; Cavalcante JL; de Potter T; Doenst T; Friedrichs K; Hausleiter J; Karam N; Kodali S; Latib A; Marijon E; Mittal S; Nickenig G; Rinaldi A; Rudzinski PN; Russo M; Starck C; von Bardeleben RS; Wunderlich N; Zamorano JL; Hahn RT; Maisano F; Leclercq C Eur Heart J; 2024 Feb; 45(5):346-365. PubMed ID: 38096587 [TBL] [Abstract][Full Text] [Related]
26. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508 [TBL] [Abstract][Full Text] [Related]
27. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. Kim JB; Spevack DM; Tunick PA; Bullinga JR; Kronzon I; Chinitz LA; Reynolds HR J Am Soc Echocardiogr; 2008 Mar; 21(3):284-7. PubMed ID: 17604958 [TBL] [Abstract][Full Text] [Related]
28. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371 [TBL] [Abstract][Full Text] [Related]
29. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial. Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605 [TBL] [Abstract][Full Text] [Related]
30. Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration. Hu Q; You H; Chen K; Dai Y; Lu W; Li Y; Cheng C; Zhou Y; Wang J; Chen R; Zhang S Heart Rhythm; 2023 Feb; 20(2):217-223. PubMed ID: 36347456 [TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results. Carino D; Sala A; Zancanaro E; Ruggeri S; Lapenna E; Del Forno B; Verzini A; Schiavi D; Castiglioni A; Alfieri O; Maisano F; De Bonis M Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35426906 [TBL] [Abstract][Full Text] [Related]
32. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Outcomes in Patients With Heart Failure With Versus Without Lead-Induced Tricuspid Regurgitation After Cardiac Implantable Electronic Devices Implantations. Seo Y; Nakajima H; Ishizu T; Iida N; Sato K; Yamamoto M; Machino-Ohtsuka T; Nogami A; Ohte N; Ieda M Am J Cardiol; 2020 Sep; 130():85-93. PubMed ID: 32622503 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of tricuspid valve regurgitation following laser lead extraction†. Pecha S; Castro L; Gosau N; Linder M; Vogler J; Willems S; Reichenspurner H; Hakmi S Eur J Cardiothorac Surg; 2017 Jun; 51(6):1108-1111. PubMed ID: 28204134 [TBL] [Abstract][Full Text] [Related]
35. Discontinuation of cardiac implantable electronic device therapy after transvenous lead extraction. Kutarski A; Jacheć W; Kosior J; Stec S; Nowosielecka D; Polewczyk A Kardiol Pol; 2023; 81(11):1113-1121. PubMed ID: 37937353 [TBL] [Abstract][Full Text] [Related]
36. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Al-Bawardy R; Krishnaswamy A; Bhargava M; Dunn J; Wazni O; Tuzcu EM; Stewart W; Kapadia SR Clin Cardiol; 2013 May; 36(5):249-54. PubMed ID: 23529935 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. Taramasso M; Gavazzoni M; Pozzoli A; Alessandrini H; Latib A; Attinger-Toller A; Biasco L; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Louriero R; Fam N; Frerker C; Ho E; Juliard JM; Kaple R; Kodali S; Kreidel F; Kuck KH; Lauten A; Lurz J; Monivas V; Mehr M; Nazif T; Nickening G; Pedrazzini G; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Khattab AA; Thiele H; Unterhuber M; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Hausleiter J; Lurz P; Maisano F; Leon MB; Hahn RT JACC Cardiovasc Interv; 2020 Mar; 13(5):554-564. PubMed ID: 31954676 [TBL] [Abstract][Full Text] [Related]
38. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery. Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074 [TBL] [Abstract][Full Text] [Related]
39. Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation. Van De Heyning CM; Elbarasi E; Masiero S; Brambatti M; Ghazal S; Al-Maashani S; Capucci A; Leong D; Shivalkar B; Saenen JB; Miljoen HP; Morillo CA; Divarakarmenon S; Amit G; Ribas S; Baiocco E; Maolo A; Romandini A; Maffei S; Connolly SJ; Healey JS; Dokainish H Can J Cardiol; 2019 Apr; 35(4):389-395. PubMed ID: 30852048 [TBL] [Abstract][Full Text] [Related]
40. Revisiting predictors of worse atrioventricular valve and left ventricular systolic function following pacemaker therapy. Sasaki K; Togashi D; Nakajima I; Nakayama Y; Harada T; Akashi YJ Pacing Clin Electrophysiol; 2023 Dec; 46(12):1643-1651. PubMed ID: 37904603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]